TY - JOUR T1 - Willingness of Nigerian residents to disclose COVID-19 symptoms and take COVID-19 test JF - medRxiv DO - 10.1101/2020.10.02.20205914 SP - 2020.10.02.20205914 AU - Victoria Oladoyin AU - Oluyemi Okunlola AU - Oluwaseyi Israel AU - Demilade Ibirongbe AU - Joy Osifo AU - Taiwo Obembe AU - Paulinus Omode AU - Olugbenga Osunmakinwa Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/05/2020.10.02.20205914.abstract N2 - Background An understanding of willingness of people to disclose coronavirus disease 2019 (COVID-19) symptoms and take the COVID-19 test will help provide important insight for motivators towards the self-surveillance and testing strategies recommended by the World Health Organization to curtail and halt the transmission of COVID-19.Objectives This study assessed willingness to disclose symptoms suggestive of COVID-19 and willingness to take COVID-19 test as well as their predictors.Methods A cross-sectional online survey of 524 Nigerian adults, aged ≥ 18 years, residing in Nigeria and who had not taken the COVID-19 test was conducted. Information on willingness to disclose COVID-19 symptoms, take COVID-19 test and possible predictors were collected. Data were analysed using descriptive and inferential statistics evaluated at 5% significance level.Results Mean age of respondents was 35.8 ± 10.7 years and 57.0% were males. Majority (85.8% and 86.2% respectively) were willing to disclose COVID-19 symptoms and take COVID-19 test. Self-risk perception of contracting COVID-19 predicted both willingness to disclose COVID-19 symptoms (aOR=3.236; 95%CI=1.836-5.704) and take COVID-19 test (aOR=3.174; 95%CI=1.570-6.419). Willingness to disclose COVID-19 symptoms (aOR=13.060; 95%CI= 6.253-27.276), knowledge of someone who had taken the test (aOR= 4.106; 95%CI= 1.179-14.299) and thought that it was important for people to know their COVID-19 status (aOR=3.123; 95%CI= 1.516-6.434) also predicted willingness to take COVID-19 test.Conclusion Nigerians are willing to disclose symptoms suggestive of COVID-19 and take the COVID-19 test. Investment in interventions developed based on the predicting factors will help speed up the finding and testing of suspected COVID-19 cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors declare that this work was not fundedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval to conduct the study was obtained from the Ondo State Health Research Ethics Committee with study protocol number OSHREC/28/05/20/268.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are available upon request ER -